| Identification | Back Directory | [Name]
4-Piperidinamine, N-[3-[[6,7-dimethoxy-2-[4-(trifluoromethyl)phenyl]-4-quinolinyl]oxy]propyl]-1-methyl- | [CAS]
2764772-88-3 | [Synonyms]
EGFR-IN-46 4-Piperidinamine, N-[3-[[6,7-dimethoxy-2-[4-(trifluoromethyl)phenyl]-4-quinolinyl]oxy]propyl]-1-methyl- | [Molecular Formula]
C27H32F3N3O3 | [MOL File]
2764772-88-3.mol | [Molecular Weight]
503.56 |
| Hazard Information | Back Directory | [Uses]
EGFR-IN-46 is a potent EGFR and FAK dual inhibitor with IC50s of 20.17 nM, 14.25 nM, respectively. EGFR-IN-46 significantly inhibits the growth of cancer cells. EGFR-IN-46 induces cell apoptosis[1]. | [IC 50]
EGFR: 20.17 nM (IC50); FAK: 14.25 nM (IC50) | [References]
[1] Elbadawi MM, et al. 2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights. J Enzyme Inhib Med Chem. 2022 Dec;37(1):349-372. DOI:10.1080/14756366.2021.2015344 |
|
|